Lactiplantibacillus plantarum Q180
Product description
Lactiplantibacillus plantarum Q180, researched by CKD BIO, has been clinically proven to lower postprandial blood lipid levels within 12 weeks. This strain can be utilized in various health supplements, including powders and capsules. It is produced in facilities that meet GMP standards and possesses MUI Halal certification.
Read more
Specifications
Categories | Food Supplements / Nutraceuticals; Probiotics |
---|
More products from CKD BiO Corporation
Lactiplantibacillus plantarum Q180